43 POSTER Assessment of predictive biological markers with an oral angiogenic receptor tyrosine kinase (RTK) inhibitor, TSU-68, in the Phase I/II study for advanced hepatocellular carcinoma (HCC)

✍ Scribed by T. Okusaka; F. Kanai; M. Ikeda; C. Morizane; H. Yoshida; R. Tateishi; S. Shiina; Y. Kondo; K. Tagawa; M. Omata

• Book ID: 119599198
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 65 KB
• Volume: 6
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(08)71975-x